Purpose: By using data that exists in the ImproveCareNow Registry, this study aims to measure the duration and effect of adalimumab on clinical outcomes in pediatric ulcerative colitis patients in the clinical practice setting. This study will add to the knowledge about the use of adalimumab as therapy in the management of pediatric ulcerative colitis.
Funding Source (Year Awarded): AbbVie (2016)
Study Period: 2016-2017
Recruitment Status: This study makes use of existing data in the ICN registry.
Contact: ImproveCareNow Research
More information: